Related Experiment Video
Updated: Nov 9, 2025

Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
Heart transplant in Jehovah's Witness patients: A case-control study
Sukhjot Sander1, Tahli Singer-Englar2, Keith Nishihara3
1Department of Internal Medicine, Smidt Heart Institute, Cedars-Sinai, Los Angeles, California.
Insights
Heart transplantation is a viable option for Jehovah's Witnesses (JW) patients who decline blood transfusions. Carefully selected JW recipients demonstrated comparable outcomes to non-JW patients one year post-heart transplant.
Area of Science:
- Cardiology
- Transplantation Medicine
- Medical Ethics
Background:
- Heart transplantation (HTx) offers improved survival and quality of life for advanced heart failure patients.
- Jehovah's Witnesses (JW) patients' refusal of blood transfusions presents challenges for HTx candidacy at many institutions.
Purpose of the Study:
- To evaluate the feasibility and outcomes of heart transplantation in Jehovah's Witnesses (JW) patients who decline blood products.
- To compare the outcomes of JW HTx recipients with non-JW control patients.
Main Methods:
- Retrospective review of 20 consecutive JW patients referred for HTx consideration.
- Analysis of 8 JW patients who underwent HTx and comparison with matched non-JW controls without prior cardiac surgery.
- Assessment of primary graft dysfunction, rejection, allograft vasculopathy, survival, and hemoglobin levels up to 1 year post-transplant.
Main Results:
- Seven of 20 JW patients were declined HTx for specific medical reasons.
- Eight JW patients underwent HTx and showed comparable rates of primary graft dysfunction, rejection, and allograft vasculopathy to controls.
- Survival and hemoglobin levels were similar between JW and non-JW HTx recipients at 1 year.
Conclusions:
- Heart transplantation can be successfully performed in selected Jehovah's Witnesses (JW) patients who decline blood products.
- Appropriate patient selection is crucial for achieving favorable outcomes in this patient population.
- This study supports the expansion of HTx candidacy for JW patients adhering to their religious beliefs.
Abstract:
Heart transplantation (HTx) improves quality of life and survival in patients with advanced heart failure. Jehovah's Witnesses (JW) patients decline blood transfusion (including red cells, plasma and platelets) and are prohibited from heart transplantation at many centers. We report our experience with 20 consecutive JW patients with advanced heart failure who declined blood products referred to our center for HTx consideration. Of these, 7 were declined for transplant due to prior sternotomy, need for multi-organ transplant, or being too well. Of 13 JW patients accepted for heart transplant listing, 8 underwent HTx at our center. Compared to non-JW controls without prior cardiac surgery matched for age and listing status, JW HTx recipients had comparable incidence of primary graft dysfunction, rejection, allograft vasculopathy, and survival and hemoglobin up to 1 year. With appropriate selection, patients who are JW and decline blood products may successfully undergo heart transplantation.
Related Concept Videos
Kidney Transplant I: Introduction
Rheumatic Heart Disease I: Introduction
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Rheumatic Heart Disease III: Medical Management
Kidney Transplant II: Surgical Procedure
Heart Failure I: Introduction

